Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aravindhan Veerapandiyan

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscular Dystrophy, Duchenne
8
2024
24
3.470
Why?
Muscular Atrophy, Spinal
5
2024
13
3.060
Why?
Oligonucleotides
4
2020
80
2.080
Why?
Genetic Therapy
6
2024
120
1.880
Why?
Pneumonia, Viral
3
2020
169
1.660
Why?
Coronavirus Infections
3
2020
178
1.630
Why?
Spastic Paraplegia, Hereditary
2
2022
2
1.590
Why?
Mutation
12
2023
1280
1.520
Why?
Disease Management
2
2020
178
1.240
Why?
Dystonic Disorders
2
2023
6
1.210
Why?
Pandemics
4
2022
563
1.130
Why?
Humans
49
2024
50503
0.990
Why?
Spasms, Infantile
2
2018
29
0.960
Why?
Child
23
2024
6906
0.960
Why?
Epilepsy
2
2022
180
0.950
Why?
Neuromuscular Diseases
1
2024
30
0.890
Why?
Spinal Muscular Atrophies of Childhood
2
2020
9
0.880
Why?
Recombinant Fusion Proteins
2
2024
179
0.870
Why?
Peroneal Neuropathies
2
2021
5
0.870
Why?
Intellectual Disability
2
2022
127
0.860
Why?
Dystonia
1
2023
10
0.850
Why?
Nerve Tissue Proteins
2
2021
194
0.790
Why?
Myasthenic Syndromes, Congenital
1
2021
8
0.760
Why?
Chromosomes, Human, Pair 22
2
2011
37
0.730
Why?
Adolescent
17
2024
6443
0.720
Why?
Fasciculation
1
2020
2
0.720
Why?
Isaacs Syndrome
1
2020
2
0.720
Why?
Hereditary Sensory and Motor Neuropathy
1
2020
3
0.710
Why?
Seizures
3
2018
195
0.710
Why?
Male
29
2024
25907
0.710
Why?
Muscular Dystrophies
1
2020
15
0.700
Why?
Myopathies, Structural, Congenital
1
2020
10
0.700
Why?
Consensus
2
2024
160
0.690
Why?
Codon, Nonsense
1
2020
26
0.690
Why?
Anticonvulsants
2
2012
123
0.690
Why?
Apoptosis Regulatory Proteins
1
2020
82
0.680
Why?
Charcot-Marie-Tooth Disease
1
2019
8
0.670
Why?
Glucocorticoids
3
2020
230
0.670
Why?
Phenotype
3
2020
739
0.670
Why?
Epstein-Barr Virus Infections
1
2020
30
0.670
Why?
Encephalitis
2
2017
40
0.640
Why?
Adaptor Proteins, Signal Transducing
1
2020
198
0.640
Why?
Multiple Sclerosis
1
2019
65
0.640
Why?
Infant
9
2020
3628
0.630
Why?
Chromosome Duplication
1
2018
7
0.620
Why?
Survival of Motor Neuron 1 Protein
1
2018
3
0.620
Why?
Munc18 Proteins
1
2018
3
0.610
Why?
Child, Preschool
13
2024
3942
0.610
Why?
Spinal Puncture
1
2018
17
0.600
Why?
Microfilament Proteins
1
2018
42
0.600
Why?
Electroencephalography
6
2018
304
0.600
Why?
Dystrophin
3
2024
6
0.600
Why?
Epilepsies, Myoclonic
1
2018
12
0.600
Why?
Attention Deficit Disorder with Hyperactivity
2
2024
172
0.590
Why?
Head
1
2018
70
0.590
Why?
Chromosomes, Human, Pair 1
1
2018
92
0.590
Why?
Chromosome Deletion
3
2018
134
0.570
Why?
Delivery of Health Care
1
2020
303
0.560
Why?
Central Nervous System Diseases
1
2017
25
0.560
Why?
Pedigree
3
2022
119
0.550
Why?
Carrier Proteins
1
2018
298
0.530
Why?
Muscular Diseases
2
2020
61
0.510
Why?
Female
20
2024
27081
0.470
Why?
DiGeorge Syndrome
2
2012
17
0.460
Why?
Emergency Service, Hospital
1
2018
484
0.460
Why?
Tomography, X-Ray Computed
1
2018
1164
0.410
Why?
Brain
2
2018
1319
0.400
Why?
Epilepsy, Complex Partial
1
2012
3
0.400
Why?
Carbamazepine
1
2012
13
0.400
Why?
Epilepsy, Tonic-Clonic
1
2011
3
0.370
Why?
Pyridoxal Phosphate
1
2011
10
0.370
Why?
Cephalometry
1
2011
18
0.370
Why?
Myoglobinuria
1
2010
2
0.360
Why?
Triazines
1
2011
24
0.360
Why?
Epilepsy, Absence
1
2011
11
0.360
Why?
Ocular Motility Disorders
1
2011
17
0.360
Why?
BRCA2 Protein
1
2010
16
0.360
Why?
Velopharyngeal Insufficiency
1
2011
17
0.360
Why?
Pseudolymphoma
1
2010
4
0.360
Why?
Retrospective Studies
7
2021
6263
0.350
Why?
Prednisolone
3
2020
53
0.350
Why?
Mutation, Missense
1
2010
103
0.340
Why?
Treatment Outcome
5
2024
5283
0.330
Why?
Drug Overdose
1
2011
159
0.310
Why?
Diagnosis, Differential
3
2020
1033
0.290
Why?
Myocarditis
2
2024
46
0.280
Why?
Young Adult
7
2024
4102
0.270
Why?
Drug Therapy, Combination
2
2020
384
0.240
Why?
Follow-Up Studies
3
2021
2242
0.240
Why?
Muscle, Skeletal
1
2010
784
0.240
Why?
Gene Transfer Techniques
1
2024
41
0.240
Why?
Heterozygote
2
2023
83
0.240
Why?
Dependovirus
1
2024
102
0.220
Why?
Mental Disorders
2
2024
415
0.210
Why?
Histone-Lysine N-Methyltransferase
1
2023
54
0.210
Why?
Magnetic Resonance Imaging
3
2018
1548
0.200
Why?
Adenosine Triphosphatases
1
2022
87
0.200
Why?
Adult
8
2024
13577
0.190
Why?
Semaphorins
1
2021
4
0.190
Why?
Atrophy
1
2022
37
0.190
Why?
Patient Care Planning
1
2022
66
0.190
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2021
4
0.190
Why?
Cell Adhesion Molecules
1
2021
86
0.190
Why?
Cohort Studies
2
2018
1452
0.180
Why?
Receptors, Cell Surface
1
2021
116
0.180
Why?
Introns
2
2018
48
0.180
Why?
Muscle Cramp
1
2020
6
0.170
Why?
Recovery of Function
1
2021
191
0.170
Why?
Flavoproteins
1
2019
5
0.170
Why?
Injections, Spinal
1
2019
19
0.170
Why?
Health Services Accessibility
1
2024
424
0.170
Why?
Phosphoric Monoester Hydrolases
1
2019
20
0.170
Why?
Palliative Care
1
2022
190
0.170
Why?
Physical Endurance
1
2019
31
0.170
Why?
Hand Strength
1
2019
22
0.170
Why?
Facial Paralysis
1
2020
23
0.170
Why?
Muscle Weakness
1
2020
45
0.170
Why?
Membrane Proteins
1
2022
332
0.160
Why?
Neurologic Examination
1
2019
76
0.160
Why?
Age of Onset
1
2019
108
0.160
Why?
Steroids
1
2019
57
0.160
Why?
Abnormalities, Multiple
2
2011
167
0.160
Why?
Age Factors
3
2018
1110
0.160
Why?
Scoliosis
1
2019
60
0.160
Why?
Spinal Fusion
1
2019
69
0.160
Why?
Aminomethyltransferase
1
2018
1
0.160
Why?
Hyperglycinemia, Nonketotic
1
2018
5
0.160
Why?
Hyperammonemia
1
2018
22
0.160
Why?
Activities of Daily Living
1
2019
177
0.150
Why?
Lumbosacral Region
1
2018
12
0.150
Why?
X-Rays
1
2018
55
0.150
Why?
Anti-Inflammatory Agents
1
2019
163
0.150
Why?
Neuraminidase
1
2018
3
0.150
Why?
Mucolipidoses
1
2018
4
0.150
Why?
Pons
1
2017
33
0.140
Why?
Methylprednisolone
1
2017
39
0.140
Why?
Prevalence
1
2020
971
0.140
Why?
Brain Stem
1
2017
57
0.140
Why?
Disease Progression
1
2019
829
0.130
Why?
Cross-Sectional Studies
2
2019
1610
0.130
Why?
Quality of Life
1
2022
851
0.130
Why?
Middle Aged
4
2024
12611
0.130
Why?
T-Lymphocytes
1
2017
325
0.120
Why?
RNA, Messenger
1
2018
1089
0.120
Why?
Chronic Disease
1
2017
573
0.120
Why?
Aged
3
2021
9741
0.120
Why?
Antibodies
2
2012
153
0.120
Why?
Kv1.1 Potassium Channel
1
2013
2
0.110
Why?
United States
2
2024
4955
0.110
Why?
Caregivers
2
2024
217
0.100
Why?
Dipeptides
1
2012
22
0.100
Why?
Aspartic Acid
1
2012
50
0.100
Why?
Folic Acid Deficiency
1
2012
43
0.100
Why?
Folate Receptor 1
1
2012
25
0.100
Why?
Ear
1
2011
17
0.100
Why?
Prefrontal Cortex
1
2012
86
0.100
Why?
Hypoparathyroidism
1
2011
5
0.100
Why?
Immune System Diseases
1
2011
8
0.090
Why?
Facies
1
2011
33
0.090
Why?
Eye Abnormalities
1
2011
24
0.090
Why?
Epilepsies, Partial
1
2011
12
0.090
Why?
Nose
1
2011
31
0.090
Why?
Platybasia
1
2011
5
0.090
Why?
Frontal Lobe
1
2011
48
0.090
Why?
Infant, Newborn
1
2018
2749
0.090
Why?
Receptors, N-Methyl-D-Aspartate
1
2011
127
0.090
Why?
Glycogen Storage Disease Type III
1
2010
1
0.090
Why?
Glycogen Debranching Enzyme System
1
2010
2
0.090
Why?
Cervical Vertebrae
1
2011
59
0.090
Why?
Genetic Heterogeneity
1
2010
17
0.090
Why?
Genetic Predisposition to Disease
1
2013
511
0.090
Why?
Brain Mapping
1
2011
225
0.080
Why?
Cleft Palate
1
2011
77
0.080
Why?
Syndrome
1
2010
240
0.080
Why?
Cognition Disorders
1
2011
213
0.080
Why?
Lymph Nodes
1
2010
257
0.080
Why?
Skin
1
2010
388
0.070
Why?
Myocardium
1
2010
445
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1372
0.070
Why?
Exercise
1
2010
516
0.070
Why?
Heart Defects, Congenital
1
2011
601
0.060
Why?
Obsessive-Compulsive Disorder
1
2024
44
0.060
Why?
Genetic Vectors
1
2024
128
0.060
Why?
Delphi Technique
1
2024
55
0.050
Why?
Azo Compounds
1
2022
10
0.050
Why?
Pilot Projects
1
2024
698
0.050
Why?
Health Personnel
1
2024
247
0.050
Why?
Electrodiagnosis
1
2021
12
0.050
Why?
Genetic Association Studies
1
2021
119
0.050
Why?
Pyrimidines
1
2022
191
0.040
Why?
Homozygote
1
2018
57
0.040
Why?
Prospective Studies
1
2024
2378
0.040
Why?
Signal Transduction
1
2021
1624
0.030
Why?
Flurothyl
1
2013
1
0.030
Why?
Kindling, Neurologic
1
2013
3
0.030
Why?
Mice, Mutant Strains
1
2013
69
0.030
Why?
Aged, 80 and over
1
2021
3226
0.030
Why?
Animals, Newborn
1
2013
363
0.020
Why?
Protons
1
2012
67
0.020
Why?
Hippocampus
1
2013
222
0.020
Why?
Chi-Square Distribution
1
2012
277
0.020
Why?
Magnetic Resonance Spectroscopy
1
2012
244
0.020
Why?
Autoantibodies
1
2011
117
0.020
Why?
Anisotropy
1
2011
64
0.020
Why?
Drug Resistance
1
2011
65
0.020
Why?
Video Recording
1
2011
79
0.020
Why?
Neuropsychological Tests
1
2012
355
0.020
Why?
Diffusion Magnetic Resonance Imaging
1
2011
125
0.020
Why?
Sequence Homology, Amino Acid
1
2010
144
0.020
Why?
Exons
1
2010
93
0.020
Why?
Amino Acid Sequence
1
2010
574
0.020
Why?
Molecular Sequence Data
1
2010
778
0.020
Why?
Disease Models, Animal
1
2013
1436
0.020
Why?
Mice, Inbred C57BL
1
2013
1808
0.020
Why?
Case-Control Studies
1
2011
1156
0.020
Why?
Mice
1
2013
5687
0.010
Why?
Animals
1
2013
13124
0.010
Why?
Veerapandiyan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description